Key statistics
On Friday, Hansa Biopharma AB (0RC7:LSE) closed at 41.31, -27.91% below its 52-week high of 57.30, set on Aug 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 41.39 |
---|---|
High | 41.31 |
Low | 41.31 |
Bid | 40.84 |
Offer | 42.92 |
Previous close | 40.94 |
Average volume | 6.60k |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.82bn SEK |
EPS (TTM) | -14.59 SEK |
Data delayed at least 15 minutes, as of Oct 11 2024 08:54 BST.
More ▼
Press releases
- Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
- Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update